I now have strong textbook content to compile the full answer. Let me build the comprehensive guide now.
🫁 COMMON RESPIRATORY DISEASES
Symptoms, Diagnosis & Treatment
References: Katzung's Basic & Clinical Pharmacology 16E | Fishman's Pulmonary Diseases & Disorders | Murray & Nadel's Textbook of Respiratory Medicine | Harrison's Principles of Internal Medicine 22E (2025) | Tintinalli's Emergency Medicine
MASTER OVERVIEW TABLE
| # | Disease | Key Symptom | First-Line Treatment |
|---|
| 1 | Asthma | Wheeze + SOB (reversible) | Inhaled SABA + ICS |
| 2 | COPD | Progressive exertional dyspnea, cough | LABA + LAMA + ICS (stepwise) |
| 3 | Community-Acquired Pneumonia | Fever + productive cough + consolidation | Amoxicillin / Macrolide / Fluoroquinolone |
| 4 | Tuberculosis | Chronic cough + night sweats + weight loss | RHEZ (Rifampicin, INH, Ethambutol, PZA) |
| 5 | Lung Cancer | Hemoptysis + weight loss + persistent cough | Surgery / Chemo / Radiotherapy / Immunotherapy |
| 6 | Pulmonary Embolism | Sudden dyspnea + pleuritic pain + tachycardia | Anticoagulation (heparin → warfarin/DOAC) |
| 7 | Pleural Effusion | Dullness + reduced breath sounds | Treat cause + thoracocentesis |
| 8 | Pneumothorax | Sudden sharp chest pain + absent breath sounds | Observation / Aspiration / Chest drain |
| 9 | Bronchiectasis | Chronic purulent copious sputum | Airway clearance + antibiotics |
| 10 | Interstitial Lung Disease (ILD) | Progressive dry cough + dyspnea | Steroids / Antifibrotics (pirfenidone) |
| 11 | Pulmonary Hypertension | Dyspnea + fatigue + right heart failure signs | Vasodilators + diuretics |
| 12 | Influenza | Sudden fever + myalgia + cough | Oseltamivir + supportive care |
1. ASTHMA
Definition
Chronic inflammatory airway disease with variable, reversible airflow obstruction triggered by stimuli.
Symptoms
- Episodic wheezing (hallmark)
- Shortness of breath (SOB)
- Chest tightness
- Dry cough (especially at night and early morning)
- Symptoms worsen with triggers: cold air, exercise, allergens, smoke, dust
- Symptoms improve with bronchodilators (reversibility = key feature)
Triggers (Memorize)
Allergens, exercise, cold air, NSAIDs/aspirin, smoke, stress, viral URTIs, occupational dust
Treatment - STEP-UP APPROACH
STEP 1: Mild Intermittent
→ SABA (Salbutamol/Albuterol) as needed (PRN)
↓
STEP 2: Mild Persistent
→ Low-dose Inhaled Corticosteroid (ICS)
e.g. Budesonide, Beclomethasone
↓
STEP 3: Moderate Persistent
→ Low-dose ICS + LABA
(e.g. Salmeterol + Fluticasone)
↓
STEP 4: Severe Persistent
→ High-dose ICS + LABA
↓
STEP 5: Very Severe
→ Add oral corticosteroids / biologic
(e.g. Omalizumab for allergic asthma)
Acute Attack (Emergency):
- O2 supplementation
- Nebulized SABA (salbutamol) repeatedly
- IV/oral systemic corticosteroids
- IV Magnesium sulfate (severe cases)
- Intubation if refractory
"If asthmatic symptoms occur frequently, or if significant airflow obstruction persists despite bronchodilator therapy, inhaled corticosteroids should be started." - Katzung's Pharmacology 16E
2. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Definition
Progressive, not fully reversible airflow obstruction caused by chronic inflammation due to noxious particles (mainly cigarette smoke).
- Includes: Chronic Bronchitis (productive cough ≥ 3 months for 2 consecutive years) + Emphysema
Symptoms
- Progressive exertional dyspnea (main complaint)
- Chronic productive cough (especially in the morning)
- Sputum production (white/yellow)
- Barrel chest (emphysema)
- Pursed-lip breathing
- Cyanosis in advanced disease
- Reduced exercise tolerance
- Exacerbations (acute worsening - often triggered by infection)
COPD vs Asthma - Quick Comparison
| Feature | Asthma | COPD |
|---|
| Age | Young | Older (> 40 yr) |
| Cause | Allergy/atopy | Smoking |
| Reversibility | Fully reversible | Not fully reversible |
| Inflammation | Eosinophilic | Neutrophilic |
| Response to steroids | Good | Poor |
| FEV1/FVC | < 0.7 (post-bronchodilator) | < 0.7 |
Treatment (GOLD Guidelines)
Stable COPD:
- SABA - for acute relief (salbutamol)
- LABA (salmeterol, formoterol) - regular use for persistent symptoms
- LAMA (tiotropium) - long-acting anticholinergic; reduces exacerbations
- LABA + LAMA combination - for severe disease
- ICS - only in: severe obstruction OR frequent exacerbations OR high eosinophils
- Roflumilast (PDE4 inhibitor) - reduces exacerbation frequency
- Smoking cessation - single most important intervention
- Pulmonary rehabilitation
Acute COPD Exacerbation:
- Short-acting bronchodilators (SABA ± SAMA)
- Systemic corticosteroids (prednisolone)
- Antibiotics (routine - unlike asthma): beta-lactams, doxycycline, azithromycin
- Controlled O2 therapy (target SpO2 88-92% - avoid CO2 retention)
- Non-invasive ventilation (BiPAP) if hypercapnic
"The mortality of acute COPD exacerbations is greater than that of asthma exacerbations because of greater patient age and prevalence of comorbidities." - Katzung's Pharmacology 16E
3. PNEUMONIA
Types
- Community-Acquired Pneumonia (CAP) - acquired outside hospital
- Hospital-Acquired (Nosocomial) Pneumonia - after 48h of hospitalization
- Aspiration Pneumonia - inhaled oral contents
Symptoms
- Fever (often high grade, chills, rigors)
- Productive cough - sputum (yellow/green or rust-colored in pneumococcal)
- Pleuritic chest pain (sharp, worsened by breathing)
- Dyspnea
- Tachycardia, tachypnea
- Dullness to percussion + bronchial breathing on exam
Sputum Color Clues
| Sputum Color | Think of |
|---|
| Rust-colored | Streptococcus pneumoniae |
| Currant jelly (red-brown) | Klebsiella pneumoniae |
| Foul-smelling, thick | Anaerobes / lung abscess |
| Pink frothy | Pulmonary edema (not infection) |
Treatment - CAP
OUTPATIENT (Mild CAP):
• Previously healthy, no antibiotics in past 3 months:
→ Amoxicillin 500mg TDS OR
→ Azithromycin (macrolide) OR
→ Doxycycline
OUTPATIENT (With comorbidities):
→ Amoxicillin-Clavulanate + Macrolide OR
→ Respiratory Fluoroquinolone
(Levofloxacin, Moxifloxacin)
INPATIENT (Non-ICU):
→ Beta-lactam + Macrolide OR
→ Respiratory Fluoroquinolone
INPATIENT (ICU / Severe):
→ Beta-lactam + Azithromycin + Fluoroquinolone
→ Add anti-MRSA (vancomycin) if MRSA risk
Macrolides or fluoroquinolones are used empirically since symptoms rarely differentiate among the various causes of CAP. - Goldman-Cecil Medicine
4. TUBERCULOSIS (TB)
Causative Organism
Mycobacterium tuberculosis - spread by airborne droplets
Symptoms
- Chronic cough > 2-3 weeks (often with blood)
- Hemoptysis (blood in sputum)
- Night sweats (drenching, classic)
- Unexplained weight loss ("consumption")
- Low-grade fever (afternoon)
- Fatigue, loss of appetite
- In advanced disease: pleuritic chest pain, dyspnea
Classic Triad to Memorize
Chronic cough + Night sweats + Weight loss = TB until proven otherwise
Treatment - DOTS Regimen (Standard)
PHASE 1: INTENSIVE PHASE (2 months)
┌─────────────────────────────────────┐
│ R - Rifampicin (R) │
│ H - Isoniazid (INH) │
│ E - Ethambutol │
│ Z - Pyrazinamide │
│ Mnemonic: "RHEZ" or "2RHZE" │
└─────────────────────────────────────┘
↓
PHASE 2: CONTINUATION PHASE (4 months)
┌─────────────────────────────────────┐
│ R - Rifampicin │
│ H - Isoniazid │
│ → "4RH" │
└─────────────────────────────────────┘
Total duration: 6 months (standard)
MDR-TB: 18-24 months with second-line agents
Key Drug Side Effects (Exam Favorite):
| Drug | Key Side Effect |
|---|
| Rifampicin | Orange-red urine, hepatotoxicity, enzyme inducer |
| Isoniazid | Peripheral neuropathy (give Vit B6), hepatotoxicity |
| Ethambutol | Optic neuritis (color vision loss) |
| Pyrazinamide | Hyperuricemia (gout), hepatotoxicity |
5. LUNG CANCER
Types
- Non-Small Cell Lung Cancer (NSCLC) - 85%: Adenocarcinoma, Squamous cell, Large cell
- Small Cell Lung Cancer (SCLC) - 15%: highly aggressive, paraneoplastic syndromes
Symptoms
Local symptoms:
- Persistent cough (new or changed)
- Hemoptysis (blood in sputum)
- Dyspnea / wheezing
- Chest pain (dull, constant - from chest wall invasion)
- Hoarseness (recurrent laryngeal nerve compression)
- Superior Vena Cava syndrome (facial swelling, arm swelling)
- Post-obstructive pneumonia (recurrent)
Systemic symptoms:
- Weight loss, anorexia
- Fatigue
- Bone pain (metastasis)
- Headache / neurological (brain metastasis)
Paraneoplastic syndromes (SCLC):
- SIADH (hyponatremia)
- Cushing's syndrome (ACTH)
- Eaton-Lambert syndrome (myasthenia-like)
Treatment
NSCLC:
Stage I-II → Surgery (resection) ± adjuvant chemo
Stage III → Chemoradiation
Stage IV → Chemotherapy (platinum-based)
Targeted therapy (EGFR, ALK inhibitors)
Immunotherapy (Pembrolizumab - PD-L1 high)
SCLC:
Limited stage → Chemoradiation
Extensive → Chemotherapy (etoposide + cisplatin)
+ Immunotherapy
6. PULMONARY EMBOLISM (PE)
Definition
Obstruction of pulmonary arteries by thrombus (usually from DVT of legs)
Symptoms (Classic Triad)
- Sudden-onset dyspnea (most common)
- Pleuritic chest pain (from pulmonary infarction)
- Hemoptysis (from infarction)
- Tachycardia, tachypnea
- Signs of DVT: unilateral leg swelling, pain, redness
- In massive PE: hypotension, syncope, cardiac arrest
WELLS SCORE (PE Probability)
DVT symptoms +3
No alternative diagnosis +3
HR > 100 +1.5
Immobilization / surgery (4wk) +1.5
Prior DVT/PE +1.5
Hemoptysis +1
Malignancy +1
Score > 4 = PE likely
Score ≤ 4 = PE unlikely → D-dimer first
Treatment
ACUTE PE:
→ Anticoagulation IMMEDIATELY
• LMWH (enoxaparin) or
• Unfractionated Heparin (UFH) for massive PE
MASSIVE PE (hemodynamically unstable):
→ Thrombolysis (tPA - alteplase)
→ Surgical embolectomy (if thrombolysis fails)
LONG-TERM:
→ DOACs (rivaroxaban, apixaban) - 3-6 months
→ Warfarin (target INR 2-3) - alternative
7. PNEUMOTHORAX
Types
- Spontaneous (primary - tall young men; secondary - in COPD, asthma)
- Traumatic - rib fracture, penetrating wound
- Tension pneumothorax - EMERGENCY (air with one-way valve mechanism)
Symptoms
- Sudden, sharp unilateral chest pain
- Sudden onset dyspnea
- Reduced/absent breath sounds on affected side
- Tracheal deviation away (tension PTX only - emergency sign)
- Hypotension, tachycardia (tension)
Treatment
Small PTX (<2cm, stable):
→ Observation + supplemental O2
Moderate PTX (>2cm):
→ Needle aspiration (2nd intercostal space,
midclavicular line) OR
→ Intercostal chest drain (5th ICS,
midaxillary line)
TENSION PNEUMOTHORAX (EMERGENCY):
→ Immediate needle decompression
(2nd ICS, MCL) - DO NOT WAIT FOR CXR
→ Then chest drain
8. PLEURAL EFFUSION
Definition
Abnormal accumulation of fluid in the pleural space
Symptoms
- Dyspnea (proportional to fluid volume)
- Dull aching chest pain
- Reduced chest expansion on affected side
- Stony dull percussion (classic)
- Absent breath sounds
- Tracheal deviation away (large effusion)
Exudate vs Transudate (Light's Criteria)
| Transudate | Exudate |
|---|
| Cause | HF, cirrhosis, nephrotic syndrome | Pneumonia, malignancy, TB, PE |
| Protein | < 25 g/L | > 35 g/L |
| LDH | Low | High |
Treatment
- Treat underlying cause
- Thoracocentesis (diagnostic and/or therapeutic drainage)
- Pleurodesis (for recurrent malignant effusions)
9. BRONCHIECTASIS
Definition
Permanent, abnormal dilation of bronchi due to destruction of bronchial wall (from chronic infection/inflammation)
Symptoms
- Chronic, copious purulent sputum (hallmark - "3 cupfuls a day")
- Daily productive cough
- Recurrent respiratory infections
- Hemoptysis (can be massive)
- Dyspnea
- Clubbing of fingers (chronic cases)
Causes (Mnemonic "CATFISH")
Cystic fibrosis, Allergic bronchopulmonary aspergillosis, TB, Foreign body, Immunodeficiency, Sinusitis (Kartagener), Hemorrhage
Treatment
- Airway clearance techniques (chest physiotherapy, postural drainage) - cornerstone
- Antibiotics during exacerbations (guided by sputum culture)
- Long-term low-dose azithromycin (reduces exacerbations)
- Bronchodilators (if airflow obstruction)
- Surgery (resection) for localized disease
10. INTERSTITIAL LUNG DISEASE (ILD) / PULMONARY FIBROSIS
Definition
Group of lung diseases affecting the interstitium (alveolar walls, connective tissue)
- Key type: Idiopathic Pulmonary Fibrosis (IPF)
Symptoms
- Progressive exertional dyspnea (gradual, worsening)
- Dry, non-productive cough
- Fatigue
- Bibasilar fine crackles ("Velcro crackles" on auscultation)
- Clubbing of fingers
- Cyanosis (late)
Imaging
- CXR: Bilateral reticular (net-like) opacities, predominantly lower zones
- HRCT: "Honeycombing" pattern (advanced fibrosis)
Treatment
- Antifibrotic agents: Pirfenidone, Nintedanib (slow progression in IPF)
- Corticosteroids + immunosuppressants (for inflammatory ILDs: sarcoidosis, hypersensitivity pneumonitis)
- Lung transplantation (end-stage)
- Supplemental O2, pulmonary rehab
11. INFLUENZA
Symptoms (Sudden Onset)
- High-grade fever (abrupt onset)
- Myalgia (severe muscle aches - distinguishes from common cold)
- Headache
- Dry cough
- Sore throat, runny nose
- Fatigue and malaise
- Complications: secondary bacterial pneumonia, myocarditis
Treatment
- Antiviral: Oseltamivir (Tamiflu) 75 mg BD x 5 days (within 48 hours of symptom onset)
- Supportive: Rest, fluids, paracetamol for fever
- Prevention: Annual influenza vaccination
COMPLETE DISEASE FLOWCHART
PATIENT WITH RESPIRATORY COMPLAINT
│
┌───────────────┼───────────────┐
│ │ │
COUGH DYSPNEA CHEST PAIN
│ │ │
┌───────────────────────────────┐
│ ASSESS: │
│ Duration / Onset / Character │
│ Associated symptoms │
│ Smoking / Exposure history │
└───────────────────────────────┘
│
┌───────────────┼───────────────────────────┐
│ │ │ │
ACUTE CHRONIC ACUTE GRADUAL
ONSET HISTORY SEVERE PROGRESSIVE
│ │ │ │
↓ ↓ ↓ ↓
Pneumonia/ COPD/TB/ PE / PTX COPD / ILD /
Influenza/ Lung Cancer/ / Asthma Pulmonary HT
PE Bronchiectasis attack / Lung Cancer
│ │ │ │
↓ ↓ ↓ ↓
Antibiotics/ See Disease Emergency Stepwise
Antivirals Specific Rx Protocol Long-term Rx
DRUG CLASSES SUMMARY TABLE
| Drug Class | Examples | Used In |
|---|
| SABA (Short-acting β2 agonist) | Salbutamol (albuterol) | Asthma (rescue), COPD |
| LABA (Long-acting β2 agonist) | Salmeterol, Formoterol | Asthma (step 3+), COPD |
| LAMA (Long-acting anticholinergic) | Tiotropium | COPD (preferred) |
| ICS (Inhaled corticosteroid) | Budesonide, Fluticasone | Asthma (controller), COPD severe |
| Oral corticosteroids | Prednisolone | Acute asthma/COPD exacerbation |
| Antitubercular | RHEZ (Rifampicin, INH, Ethambutol, PZA) | TB |
| Antibiotics | Amoxicillin, Azithromycin, Levofloxacin | Pneumonia, COPD exacerbation |
| Anticoagulants | Heparin, DOACs, Warfarin | PE, DVT |
| Antifibrotics | Pirfenidone, Nintedanib | IPF |
| Antiviral | Oseltamivir | Influenza |
| Biologic | Omalizumab, Mepolizumab | Severe allergic/eosinophilic asthma |
REFERENCES
- Katzung's Basic and Clinical Pharmacology, 16th Edition - Treatment of Asthma and COPD
- Fishman's Pulmonary Diseases and Disorders, 2-Volume Set - Approach to Respiratory Symptoms, Hemoptysis, PE
- Murray & Nadel's Textbook of Respiratory Medicine, 2-Volume - Cough, Dyspnea, TB treatment
- Harrison's Principles of Internal Medicine, 22nd Edition (2025) - Community-Acquired Pneumonia, Hemoptysis, Lung Cancer
- Tintinalli's Emergency Medicine: A Comprehensive Study - Active TB Treatment, PE, Emergency Management
- Goldman-Cecil Medicine International Edition - CAP Management, Diagnosis